VanEck ETF Trust - VanEck Pharmaceutical ETF
US ˙ NasdaqGM ˙ US92189F6925

SecurityPPH / VanEck ETF Trust - VanEck Pharmaceutical ETF
InstitutionUBS Group AG
Latest Disclosed Ownership54,964 shares
Latest Disclosed Value $ 5,709,660
UBS Group AG ownership in PPH / VanEck ETF Trust - VanEck Pharmaceutical ETF

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 54,964 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF (US:PPH) valued at $5,709,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 107,379 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF. This represents a change in shares of -48.81% during the quarter. The current value of the position is $5,581,594 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PPH) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PPH / VanEck ETF Trust - VanEck Pharmaceutical ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 54,964 -52,415 -48.81 5,710 -48.47 0.0009
2026-01-29 2025-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 107,379 63,692 145.79 11,078 180.67 0.0018
2025-11-13 2025-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 43,687 -120,031 -73.32 3,948 -72.59 0.0006
2025-08-14 2025-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 163,718 -58,289 -26.26 14,401 -28.82 0.0025
2025-05-13 2025-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 222,007 204,864 1,195.03 20,231 1,267.88 0.0037
2025-02-14 2024-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 17,143 219 1.29 1,479 -8.02 0.0003
2024-11-14 2024-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 16,924 1,840 12.20 1,608 16.61 0.0004
2024-08-14 2024-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 15,084 -526 -3.37 1,380 -2.54 0.0003
2024-05-13 2024-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 15,610 2,067 15.26 1,416 28.52 0.0004
2024-02-09 2023-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 13,543 2,621 24.00 1,102 26.26 0.0003
2023-11-09 2023-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 10,922 -1,516 -12.19 872 -10.93 0.0003
2023-08-11 2023-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 12,438 -1,636 -11.62 980 -10.35 0.0003
2023-05-12 2023-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 14,074 -398,355 -96.59 1,093 -96.59 0.0004
2023-02-08 2022-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 412,429 -97,343 -19.10 32,062 -6.46 0.0120
2022-11-10 2022-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 509,772 15,436 3.12 34,277 -9.76 0.0150
2022-08-10 2022-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 494,336 481,598 3,780.80 37,985 3,638.68 0.0156
2022-05-16 2022-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 12,738 6,981 121.26 1,016 129.35 0.0003
2022-02-14 2021-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 5,757 -1,777 -23.59 443 -19.16 0.0001
2021-11-15 2021-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 7,534 1,294 20.74 548 20.18 0.0002
2021-08-13 2021-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 6,240 -4,161 -40.01 456 -36.49 0.0001
2021-05-12 2021-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 10,401 4,069 64.26 718 70.55 0.0002
2021-02-11 2020-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 6,332 -595 -8.59 421 -2.09 0.0001
2020-11-12 2020-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 6,927 -699 -9.17 430 -9.47 0.0002
2020-07-31 2020-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 7,626 -3,596 -32.04 475 -22.26 0.0002
2020-05-01 2020-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 11,222 -1,266 -10.14 611 -23.82 0.0003
2020-02-14 2019-12-31 13F VANECK VECTORS ETF TRUST PHARMACEUTICAL 92189F692 12,488 2,436 24.23 802 39.97 0.0003
2019-11-14 2019-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 10,052 -1,767 -14.95 573 -17.32 0.0002
2019-08-14 2019-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 11,819 -123 -1.03 693 -4.41 0.0003
2019-05-14 2019-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 11,942 -1,499 -11.15 725 -1.49 0.0003
2019-02-14 2018-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 13,441 -4,346 -24.43 736 -35.72 0.0003
2018-11-14 2018-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 17,787 953 5.66 1,145 15.31 0.0005
2018-08-14 2018-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 16,834 12 0.07 993 3.87 0.0004
2018-05-15 2018-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 16,822 -80,204 -82.66 956 -83.39 0.0004
2018-02-14 2017-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 97,026 -23,843 -19.73 5,754 -17.58 0.0024
2017-11-14 2017-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 120,869 14,931 14.09 6,981 11.59 0.0032
2017-11-14 2017-06-30 13F/A-1 VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 105,938 6,063 6.07 6,256 13.60 0.0032
2017-08-14 2017-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 105,938 6,256
2017-11-14 2017-03-31 13F/A-1 VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 99,875 1,423 1.45 5,507 6.54 0.0030
2017-05-12 2017-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 99,875 5,507
2017-02-14 2016-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 98,452 78,663 397.51 5,169 354.62 0.0029
2016-11-14 2016-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 19,789 3,518 21.62 1,137 19.18 0.0007
2016-08-12 2016-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL E 92189F692 16,271 16,271 954 0.0006
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 23,300 2,420 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.